Year |
Citation |
Score |
2012 |
Miki T, Xu Z, Chen-Goodspeed M, Liu M, Van Oort-Jansen A, Rea MA, Zhao Z, Lee CC, Chang KS. PML regulates PER2 nuclear localization and circadian function. The Embo Journal. 31: 1427-39. PMID 22274616 DOI: 10.1038/emboj.2012.1 |
0.318 |
|
2011 |
Chang CC, Naik MT, Huang YS, Jeng JC, Liao PH, Kuo HY, Ho CC, Hsieh YL, Lin CH, Huang NJ, Naik NM, Kung CC, Lin SY, Chen RH, Chang KS, et al. Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. Molecular Cell. 42: 62-74. PMID 21474068 DOI: 10.1016/j.molcel.2011.02.022 |
0.356 |
|
2008 |
Gao C, Cheng X, Lam M, Liu Y, Liu Q, Chang KS, Kao HY. Signal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies. Molecular Biology of the Cell. 19: 3020-7. PMID 18463162 DOI: 10.1091/Mbc.E07-11-1203 |
0.475 |
|
2008 |
Reineke EL, Lam M, Liu Q, Liu Y, Stanya KJ, Chang KS, Means AR, Kao HY. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Molecular and Cellular Biology. 28: 997-1006. PMID 18039859 DOI: 10.1128/Mcb.01848-07 |
0.403 |
|
2006 |
Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, Chao TT, Ho CC, Chen YC, Lin TP, Fang HI, Hung CC, Suen CS, Hwang MJ, Chang KS, Maul GG, et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Molecular Cell. 24: 341-54. PMID 17081986 DOI: 10.1016/j.molcel.2006.10.019 |
0.441 |
|
2005 |
Liu S, Shen T, Huynh L, Klisovic MI, Rush LJ, Ford JL, Yu J, Becknell B, Li Y, Liu C, Vukosavljevic T, Whitman SP, Chang KS, Byrd JC, Perrotti D, et al. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Research. 65: 1277-84. PMID 15735013 DOI: 10.1158/0008-5472.Can-04-4532 |
0.302 |
|
2004 |
Xu ZX, Zhao RX, Ding T, Tran TT, Zhang W, Pandolfi PP, Chang KS. Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression. The Journal of Biological Chemistry. 279: 1838-44. PMID 14597622 DOI: 10.1074/Jbc.M310987200 |
0.498 |
|
2003 |
Xu ZX, Timanova-Atanasova A, Zhao RX, Chang KS. PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Molecular and Cellular Biology. 23: 4247-56. PMID 12773567 |
0.379 |
|
2003 |
Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP, Chang KS. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway. The Journal of Biological Chemistry. 278: 12294-304. PMID 12540841 DOI: 10.1074/Jbc.M211849200 |
0.606 |
|
2002 |
Wu WS, Xu ZX, Chang KS. The promyelocytic leukemia protein represses A20-mediated transcription. The Journal of Biological Chemistry. 277: 31734-9. PMID 12080044 DOI: 10.1074/jbc.M201648200 |
0.585 |
|
2002 |
Wu WS, Xu ZX, Ran R, Meng F, Chang KS. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene. 21: 3925-33. PMID 12032831 DOI: 10.1038/sj.onc.1205491 |
0.617 |
|
2001 |
Wu WS, Vallian S, Seto E, Yang WM, Edmondson D, Roth S, Chang KS. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases Molecular and Cellular Biology. 21: 2259-2268. PMID 11259576 DOI: 10.1128/Mcb.21.7.2259-2268.2001 |
0.59 |
|
1999 |
Albitar M, Chang KS, Pierce S, Kantarjian H, Estey E. The short form of PML-RARalpha fusion transcript is associated with poor survival. Leukemia Research. 23: 89-92. PMID 9933141 DOI: 10.1016/S0145-2126(98)00087-3 |
0.326 |
|
1998 |
Vallian S, Chin K, Chang K. The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter Molecular and Cellular Biology. 18: 7147-7156. PMID 9819401 DOI: 10.1128/Mcb.18.12.7147 |
0.455 |
|
1998 |
Vallian S, Gäken JA, Gingold EB, Kouzarides T, Chang KS, Farzaneh F. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene. 16: 2843-53. PMID 9671405 DOI: 10.1038/Sj.Onc.1201837 |
0.462 |
|
1998 |
Vallian S, Gäken JA, Trayner ID, Gingold EB, Kouzarides T, Chang KS, Farzaneh F. Transcriptional repression by the promyelocytic leukemia protein, PML. Experimental Cell Research. 237: 371-82. PMID 9434633 DOI: 10.1006/Excr.1997.3801 |
0.5 |
|
1997 |
Chan JY, Li L, Fan YH, Mu ZM, Zhang WW, Chang KS. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. Biochemical and Biophysical Research Communications. 240: 640-6. PMID 9398618 DOI: 10.1006/bbrc.1997.7692 |
0.36 |
|
Show low-probability matches. |